Grown Rogue International (GRUSF) Assets (2009 - 2026)
Grown Rogue International's (GRUSF) quarterly Assets came in at $65.8 million in Q1 2026, up 35.35% year-on-year from $48.6 million in Q1 2025, and up 4.95% quarter-over-quarter from $62.7 million in Q4 2025.
Grown Rogue International (GRUSF) Assets (2009 - 2026) Analysis & Trends
Grown Rogue International's Assets history runs 17 years deep, the most recent figure standing at $65.8 million for Q1 2026.
- On a quarterly basis, Assets rose 35.35% year-over-year to $65.8 million in Q1 2026; TTM through Mar 2026 was $65.8 million, a 35.35% increase from a year earlier, with the FY2025 full-year figure at $62.7 million, up 37.47% from the prior year.
- Assets improved to $65.8 million in Q1 2026 per GRUSF's latest filing, from $62.7 million in the prior quarter.
- Across five years, Assets topped out at $55902.5 billion in Q3 2025 and bottomed at $18.8 million in Q1 2023.
- The 4-year median for Assets is $38.7 million (2024), against an average of $9452.8 billion.
- Biggest YoY gain for Assets was 184514363.33% in 2025; the steepest drop was 25.69% in 2025.
- Year by year, Assets stood at $21.8 million in 2023, then surged by 39.27% to $30.3 million in 2024, then soared by 107.07% to $62.7 million in 2025, then increased by 4.95% to $65.8 million in 2026.
- Per Business Quant, the three latest GRUSF Assets figures stand at $65.8 million (Q1 2026), $62.7 million (Q4 2025), and $55902.5 billion (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 43.40 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 40.04 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 15.15 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 98.91 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 6.71 Bn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 69.30 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 36.83 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 4.91 Bn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 13.22 Bn |
| 10 | Grown Rogue International | 99.97 Mn | 92.67 Mn | 3.96 Mn | 65.84 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 65.84 Mn |
| Dec 31, 2025 | 62.74 Mn |
| Sep 30, 2025 | 55,902.47 Bn |
| Jun 30, 2025 | 48,078.53 Bn |
| Mar 31, 2025 | 48.64 Mn |
| Sep 30, 2024 | 30.30 Mn |
| Jun 30, 2024 | 28.14 Mn |
| Mar 31, 2024 | 38.70 Mn |
| Dec 31, 2023 | 21.75 Mn |
| Apr 30, 2023 | 19.19 Mn |
| Jan 31, 2023 | 18.78 Mn |
| Apr 30, 2021 | 8.69 Mn |
| Jan 31, 2021 | 5.71 Mn |
| Oct 31, 2020 | 3.76 Mn |
| Jul 31, 2020 | 4.03 Mn |
| Apr 30, 2020 | 3.80 Mn |
| Jan 31, 2020 | 3.17 Mn |
| Oct 31, 2019 | 2.93 Mn |
| Jan 31, 2019 | 6.52 Mn |
| Oct 31, 2018 | 5.37 Mn |